MD Biosciences to Present Preclinical Disease Models at the 15th International Inflammation Research Association Conference

ST. PAUL, Minn.--(BUSINESS WIRE)--MD Biosciences, a global biotechnology company focused in inflammations & neurology research will showcase its inflammations related pre-clinical services and research products at the 15th International Inflammation Research Association (IRA) Conference, September 21-24, Chantilly, VA. Capabilities featured will be pre-clinical efficacy disease models and research products for drug discovery and research.